SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David S. who wrote (1907)9/29/1997 8:11:00 PM
From: Izzy   of 6136
 
DHSS treatment guidelines (Reuter's 9-29-97) regarding childhood HIV (AIDS) include using Viracept or Norvir PIs. Also, one of Crosson's (Montgomery) comments referred to a high failure rate of PI treatment (Viracept) in patients with "advanced stage of the disease." Clinically, what can any doctor do for a patient with terminal AIDS? I don't know of any medication(s) that will work in such situations (including patients with terminal cancer). This is not a very good reason to downgrade AGPH. Does anybody know where the PLA thread is; I need some excitement?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext